Funding boost to accelerate commercial research activity

Our hospital has received almost £2m of national funding to accelerate commercial research opportunities for patients.

NNUH has received £1.97m from the National Institute for Health and Care Research (NIHR) to increase the scale of commercial clinical research taking place to bring cutting-edge medicines and techniques into the Trust, funded by private sector organisations.

The Accelerated Commercial Research Delivery Fund (ACRDF), which will support the Trust’s commercial research provision until March 2029, aims to improve the speed and efficiency of research delivery, expand research opportunities and increase participation in clinical trials, giving our patients access to a greater number of studies and innovations.

The NNUH runs the NIHR Clinical Research Facility: Norfolk, which is based at the Quadram Institute on Norwich Research Park.

This funding is set to be used to help develop new principal investigators amongst the trust’s current workforce, to appoint new Clinical Research Fellows and research-focused Advanced Clinical Practitioners (ACPs). The funding will also be used to work with Norfolk GPs, enabling clinical trials to take place closer to the home, providing more of the communities under our care access to groundbreaking trials.

Dr Jenny Longmore, Director of Research Operations at NNUH, said: “We are delighted to be successful with this national funding round, which will help us to boost our commercial research activities and will ensure more of our patients have access to cutting-edge clinical trials. This funding will be key in helping to increase capacity and improve inclusion across the communities we serve.”

The award aims to find innovative approaches to address clinical services capacity issues that limit the number of healthcare research studies currently taking place and using technology and data to streamline recruitment processes.

The NIHR funding is designed to accelerate recruitment and share successful approaches across the NHS, helping make the UK a more attractive destination for pharmaceutical and life sciences investment further increasing access to cutting-edge innovations.

For more information about the funding, visit https://www.nihr.ac.uk/updates/funding-awarded-accelerate-commercial-clinical-research-delivery